Literature DB >> 16291079

Lung function in type 2 diabetes: the Normative Aging Study.

Augusto A Litonjua1, Ross Lazarus, David Sparrow, Debbie Demolles, Scott T Weiss.   

Abstract

BACKGROUND: Cross-sectional studies have noted that subjects with diabetes have lower lung function than non-diabetic subjects. We conducted this analysis to determine whether diabetic subjects have different rates of lung function change compared with non-diabetic subjects.
METHODS: We conducted a nested case-control analysis in 352 men who developed diabetes and 352 non-diabetic subjects in a longitudinal observational study of aging in men. We assessed lung function among cases and controls at three time points: Time0, prior to meeting the definition of diabetes; Time1, the point when the definition of diabetes was met; and Time2, the most recent follow-up exam.
RESULTS: Cases had lower forced expiratory volume in 1s (FEV1) and forced vital capacity (FVC) at all time points, even with adjustment for age, height, weight, and smoking. In multiple linear regression models adjusting for relevant covariates, there were no differences in rates of FEV1 or FVC change over time between cases and controls.
CONCLUSIONS: Men who are predisposed to develop diabetes have decreased lung function many years prior to the diagnosis, compared with men who do not develop diabetes. This decrement in lung function remains after the development of diabetes. We postulate that mechanisms involved in the insulin resistant state contribute to the diminished lung function observed in our subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16291079     DOI: 10.1016/j.rmed.2005.03.023

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  32 in total

1.  Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

Authors:  Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.

Authors:  Marilyn G Foreman; Xiangyang Kong; Dawn L DeMeo; Sreekumar G Pillai; Craig P Hersh; Per Bakke; Amund Gulsvik; David A Lomas; Augusto A Litonjua; Steven D Shapiro; Ruth Tal-Singer; Edwin K Silverman
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-06       Impact factor: 6.914

3.  Glycated Hemoglobin A1c, Lung Function, and Hospitalizations Among Adults with Asthma.

Authors:  Ge Yang; Yueh-Ying Han; Erick Forno; Qi Yan; Franziska Rosser; Wei Chen; Juan C Celedón
Journal:  J Allergy Clin Immunol Pract       Date:  2020-06-20

Review 4.  The diabetic lung--a new target organ?

Authors:  Dario Pitocco; Leonello Fuso; Emanuele G Conte; Francesco Zaccardi; Carola Condoluci; Giuseppe Scavone; Raffaele A Incalzi; Giovanni Ghirlanda
Journal:  Rev Diabet Stud       Date:  2012-05-10

5.  Restrictive pulmonary deficit is associated with inflammation in sub-optimally controlled obese diabetics.

Authors:  Lexley M Pinto Pereira; Terence A R Seemungal; Surujpal Teelucksingh; B Shivananda Nayak
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

6.  Subsequent mortality after hyperglycemic crisis episode in the non-elderly: a national population-based cohort study.

Authors:  Yuan Kao; Chien-Chin Hsu; Shih-Feng Weng; Hung-Jung Lin; Jhi-Joung Wang; Shih-Bin Su; Chien-Cheng Huang; How-Ran Guo
Journal:  Endocrine       Date:  2015-06-27       Impact factor: 3.633

7.  Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study.

Authors:  Rodolfo J Dennis; Dario Maldonado; Maria X Rojas; Pablo Aschner; Martin Rondón; Laura Charry; Alejandro Casas
Journal:  BMC Pulm Med       Date:  2010-07-26       Impact factor: 3.317

8.  Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy.

Authors:  William W Chance; Chanhaeng Rhee; Cuneyt Yilmaz; D Merrill Dane; M Lourdes Pruneda; Philip Raskin; Connie C W Hsia
Journal:  Diabetes Care       Date:  2008-05-20       Impact factor: 19.112

9.  Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Hsin-Chieh Yeh; Naresh M Punjabi; Nae-Yuh Wang; James S Pankow; Bruce B Duncan; Christopher E Cox; Elizabeth Selvin; Frederick L Brancati
Journal:  Diabetes Care       Date:  2007-12-04       Impact factor: 19.112

10.  Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.

Authors:  Samantha F Ehrlich; Charles P Quesenberry; Stephen K Van Den Eeden; Jun Shan; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.